A randomised cross-over study of effects of vasodilator treatment on left ventricular mass and volume in patients with chronic aortic regurgitatio
Phase 3
- Conditions
- aortic regurgitationCardiovascular - Other cardiovascular diseases
- Registration Number
- ACTRN12610000753055
- Lead Sponsor
- ational Heart Foundation of NZ
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Moderate or severe asymptomatic aortic regurgitation
Exclusion Criteria
current indication for aortic valve replacement
other clinically significant cardiac disease
contraindication to cardiac magnetic resonance imaging
atrial fibrillation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method